Laboratorios Farmaceuticos ROVI SA
F:41L
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Laboratorios Farmaceuticos ROVI SA
F:41L
|
ES |
|
Metalpha Technology Holding Ltd
NASDAQ:MATH
|
HK |
|
P
|
PT Royaltama Mulia Kontraktorindo Tbk
IDX:RMKO
|
ID |
|
I
|
ideaForge Technology Ltd
NSE:IDEAFORGE
|
IN |
|
Aubay SA
F:BAQ
|
FR |
|
Advantage Solutions Inc
NASDAQ:ADV
|
US |
|
R
|
Richy Place 2002 PCL
SET:RICHY
|
TH |
|
T
|
Thai Textile Industry PCL
SET:TTI
|
TH |
Intrinsic Value
Is 41L undervalued or overvalued?
See the intrinsic value estimate for 
Laboratorios Farmaceuticos ROVI SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
41L looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with 41L’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Laboratorios Farmaceuticos ROVI Does
Laboratorios Farmacéuticos ROVI is a Spanish drug maker that sells prescription medicines and also manufactures medicines for other pharmaceutical companies. Its own products are mainly used in hospitals and in treatments for conditions such as blood-clotting disorders and some central nervous system diseases. It also makes and sells heparin-based medicines and related ingredients, which are widely used in anticoagulant treatment.
- Headquarters
- Spain ES
- Employees
- 1 998
- IPO date
- Oct 26, 2007
Laboratorios Farmaceuticos ROVI has a narrow economic moat
Laboratorios Farmaceuticos ROVI SA has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysisLatest Earnings Call
- EPS
- €1.47
- Year ago
- €0.42
- Change
- +247%
- Stock, next trading day
- 0.0%
Revenue & Expenses Breakdown
Laboratorios Farmaceuticos ROVI SA
Earnings Waterfall
Laboratorios Farmaceuticos ROVI SA
The intrinsic value for Laboratorios Farmaceuticos ROVI SA (41L) under the Base Case is hidden EUR.
Compared with the current market price of 59.2 EUR, the stock appears hidden.